Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1)

Cited in blog · New England Journal of Medicine, 387(3), 205–216. · 2022

Jastreboff AM (2022). Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). *New England Journal of Medicine*, 387(3), 205–216.

Authors

Jastreboff AM

Research lens

Jastreboff AM (2022). Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). *New England Journal of Medicine*, 387(3), 205–216.

  • blog
  • glp1-protein-demand-circana-2026-09-04